Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNeurology

Optimizing Longitudinal Amyloid-β PET Measurement: The Challenges of Intensity Normalization

Susan M. Landau
Journal of Nuclear Medicine October 2018, 59 (10) 1581-1582; DOI: https://doi.org/10.2967/jnumed.118.212662
Susan M. Landau
Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, California; and Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 59 no. 10 1581-1582
DOI 
https://doi.org/10.2967/jnumed.118.212662
PubMed 
30213847

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication September 7, 2018
  • Accepted for publication September 10, 2018
  • Published online October 1, 2018.

Article Versions

  • previous version (September 13, 2018 - 11:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 18F‐FDG PET, the early phases and the delivery rate of 18F‐AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O‐H2O PET
    Julie Ottoy, Jeroen Verhaeghe, Ellis Niemantsverdriet, Ellen De Roeck, Leonie Wyffels, Sarah Ceyssens, Christine Van Broeckhoven, Sebastiaan Engelborghs, Sigrid Stroobants, Steven Staelens
    Alzheimer's & Dementia 2019 15 9
  • Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?
    Kevin McRae‐McKee, Chinedu T. Udeh‐Momoh, Geraint Price, Sumali Bajaj, Celeste A. de Jager, David Scott, Christoforos Hadjichrysanthou, Emily McNaughton, Luc Bracoud, Sara Ahmadi‐Abhari, Frank de Wolf, Roy M. Anderson, Lefkos T. Middleton
    Alzheimer's & Dementia 2019 15 10
  • Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer’s disease
    Elizabeth Levitis, Jacob W Vogel, Thomas Funck, Vladimir Hachinski, Serge Gauthier, Jonathan Vöglein, Johannes Levin, Brian A Gordon, Tammie Benzinger, Yasser Iturria-Medina, Alan C Evans
    Brain Communications 2022 4 3
  • Change in Depressive Symptoms and Longitudinal Regional Amyloid Accumulation in Unimpaired Older Adults
    Catherine E. Munro, Michelle Farrell, Bernard Hanseeuw, Dorene M. Rentz, Rachel Buckley, Michael Properzi, Ziwen Yuan, Patrizia Vannini, Rebecca E. Amariglio, Yakeel T. Quiroz, Deborah Blacker, Reisa A. Sperling, Keith A. Johnson, Gad A. Marshall, Jennifer R. Gatchel
    JAMA Network Open 2024 7 8
  • Cerebral Amyloid Quantification in Cognitively Normal Korean Adults Using F-18 Florbetaben PET
    Jieun Jeong, Young Jin Jeong, Kyung Won Park, Do-Young Kang
    Nuclear Medicine and Molecular Imaging 2019 53 5

Article usage

Article usage: September 2018 to April 2025

AbstractFullPdf
Sep 20181041
Oct 20181264118
Nov 201806731
Dec 201805515
Jan 201904420
Feb 201903513
Mar 201903813
Apr 20191289
May 201902711
Jun 20190439
Jul 20190334
Aug 20190104
Sep 20190225
Oct 201904312
Nov 201902823
Dec 20190234
Jan 20200234
Feb 2020096
Mar 202001912
Apr 202001712
May 20200169
Jun 20200147
Jul 202001014
Aug 2020092
Sep 20200166
Oct 20200238
Nov 20200144
Dec 20200104
Jan 20210148
Feb 20210139
Mar 20210813
Apr 20210231
May 202101917
Jun 20210106
Jul 20210147
Aug 202101513
Sep 20210127
Oct 20210621
Nov 202101630
Dec 202101920
Jan 20220129
Feb 20220143
Mar 20220113
Apr 2022065
May 202201010
Jun 20220128
Jul 20220151
Aug 2022086
Sep 2022048
Oct 2022078
Nov 20220102
Dec 2022041
Jan 20230165
Feb 2023067
Mar 20230104
Apr 20230231
May 20230104
Jun 2023057
Jul 20230132
Aug 2023053
Sep 2023043
Oct 2023046
Nov 2023076
Dec 20230220
Jan 2024084
Feb 2024032
Mar 20240524
Apr 20240615
May 20240152
Jun 20240118
Jul 20240810
Aug 20240229
Sep 20240126
Oct 20240187
Nov 20240610
Dec 20240123
Jan 2025096
Feb 20250364
Mar 202502514
Apr 202502413
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (10)
Journal of Nuclear Medicine
Vol. 59, Issue 10
October 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimizing Longitudinal Amyloid-β PET Measurement: The Challenges of Intensity Normalization
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Optimizing Longitudinal Amyloid-β PET Measurement: The Challenges of Intensity Normalization
Susan M. Landau
Journal of Nuclear Medicine Oct 2018, 59 (10) 1581-1582; DOI: 10.2967/jnumed.118.212662

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optimizing Longitudinal Amyloid-β PET Measurement: The Challenges of Intensity Normalization
Susan M. Landau
Journal of Nuclear Medicine Oct 2018, 59 (10) 1581-1582; DOI: 10.2967/jnumed.118.212662
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition
  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimers disease
  • Google Scholar

More in this TOC Section

Neurology

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Show more Neurology

Clinical

  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
Show more Clinical

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire